1. Home
  2. BAK vs ACHV Comparison

BAK vs ACHV Comparison

Compare BAK & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braskem SA ADR

BAK

Braskem SA ADR

N/A

Current Price

$1.82

Market Cap

713.3M

Sector

Industrials

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$7.38

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAK
ACHV
Founded
1972
N/A
Country
Brazil
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
713.3M
726.5M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
BAK
ACHV
Price
$1.82
$7.38
Analyst Decision
Sell
Strong Buy
Analyst Count
6
12
Target Price
$1.90
★ $14.15
AVG Volume (30 Days)
★ 1.7M
1.3M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.44
N/A
Revenue Next Year
$4.41
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$2.62
52 Week High
$5.40
$8.64

Technical Indicators

Market Signals
Indicator
BAK
ACHV
Relative Strength Index (RSI) 53.50 47.22
Support Level $1.40 $7.01
Resistance Level $2.16 $8.49
Average True Range (ATR) 0.11 0.40
MACD 0.04 -0.07
Stochastic Oscillator 82.47 33.96

Price Performance

Historical Comparison
BAK
ACHV

About BAK Braskem SA ADR

Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: